Advertisement

Monash Bioethics Review

, Volume 33, Issue 2–3, pp 130–147 | Cite as

Ethics for pandemics beyond influenza: Ebola, drug-resistant tuberculosis, and anticipating future ethical challenges in pandemic preparedness and response

  • Maxwell J. SmithEmail author
  • Diego S. Silva
Original Article

Abstract

The unprecedented outbreak of Ebola virus disease (EVD) in West Africa has raised several novel ethical issues for global outbreak preparedness. It has also illustrated that familiar ethical issues in infectious disease management endure despite considerable efforts to understand and mitigate such issues in the wake of past outbreaks. To improve future global outbreak preparedness and response, we must examine these shortcomings and reflect upon the current state of ethical preparedness. To this end, we focus our efforts in this article on the examination of one substantial area: ethical guidance in pandemic plans. We argue that, due in part to their focus on considerations arising specifically in relation to pandemics of influenza origin, pandemic plans and their existing ethical guidance are ill-equipped to anticipate and facilitate the navigation of unique ethical challenges that may arise in other infectious disease pandemics. We proceed by outlining three reasons why this is so, and situate our analysis in the context of the EVD outbreak and the threat posed by drug-resistant tuberculosis: (1) different infectious diseases have distinct characteristics that challenge anticipated or existing modes of pandemic prevention, preparedness, response, and recovery, (2) clear, transparent, context-specific ethical reasoning and justification within current influenza pandemic plans are lacking, and (3) current plans neglect the context of how other significant pandemics may manifest. We conclude the article with several options for reflecting upon and ultimately addressing ethical issues that may emerge with different infectious disease pandemics.

Keywords

Ebola Ethics Pandemic planning Pandemic preparedness Public health emergency preparedness and response All-hazards planning Tuberculosis 

Notes

Acknowledgments

The authors would like to thank Fondation Brocher for the opportunity to develop this article during a stay as visiting researchers.

Compliance with ethical standards

Conflict of interest

No conflicts of interest to declare.

References

  1. Adebamowo, C., O. Bah-Sow, F. Binka, R. Bruzzone, A. Caplan, J. Delfraissy, D. Heymann, P. Horby, P. Kaleebu, J. Muyembe Tamfum, P. Olliaroemail, P. Piot, A. Tejan-Cole, O. Tomori, A. Toure, E. Torreele, and J. Whitehead. 2014. Randomised controlled trials for Ebola: Practical and ethical issues. The Lancet 384: 1423–1424.CrossRefGoogle Scholar
  2. Ahn, M.J., A. Grimwood, H. Schwarzwald, and A. Herman. 2003. Ethics and the AIDS pandemic in the developing world. Journal of the International Association of Physicians in AIDS Care 2: 81–87.CrossRefGoogle Scholar
  3. Australian Government Department of Health. 2014. Australian health management plan for pandemic influenza. https://www.health.gov.au/internet/main/publishing.nsf/Content/519F9392797E2DDCCA257D47001B9948/$File/AHMPPI.pdf. Accessed 6 Aug 2015.Google Scholar
  4. Battin, M.P., L.P. Francis, J.A. Jacobson, and C.B. Smith. 2008. The patient as victim and vector: Ethics and infectious disease. New York: Oxford University Press.Google Scholar
  5. Bayer, R. 1991. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? New England Journal of Medicine 324: 1500–1504.CrossRefGoogle Scholar
  6. Bayer, R., N.N. Dubler, and S. Landesman. 1993. The dual epidemics of tuberculosis and AIDS: Ethical and policy issues in screening and treatment. American Journal of Public Health 83: 649–654.CrossRefGoogle Scholar
  7. Benatar, S.R. 2002. The HIV/AIDS pandemic: A sign of instability in a complex global system. Journal of Medicine and Philosophy 27: 163–177.CrossRefGoogle Scholar
  8. Berkman, B.E. 2009. Incorporating explicit ethical reasoning into pandemic influenza policies. Journal of Contemporary Health Law and Policy 26: 1–19.Google Scholar
  9. Caplan, A.L., C. Plunkett, and B. Levin. 2015. Selecting the right tool for the job. American Journal of Bioethics 15: 4–10.CrossRefGoogle Scholar
  10. Darrow, J.J., A. Sarpatwari, J. Avorn, and A.S. Kesselheim. 2015. Practical, legal, and ethical issues in expanded access to investigational drugs. New England Journal of Medicine 372: 279–286.CrossRefGoogle Scholar
  11. Derpmann, S. 2011. Ethical reasoning in pandemic preparedness plans: Southeast Asia and the Western Pacific. Bioethics. doi: 10.1111/j.1467-8519.2011.01922.x.Google Scholar
  12. Dheda, K., T. Gumbo, N.R. Gandhi, M. Murray, G. Theron, Z. Uwadia, G.B. Migliori, and R. Warren. 2014. Global control of tuberculosis: From extensively drug-resistant to untreatable tuberculosis. The Lancet Respiratory Medicine 2: 321–338.CrossRefGoogle Scholar
  13. Donovan, G.K. 2014. Ebola, epidemics, and ethics—What we have learned. Philosophy, Ethics, and Humanities in Medicine. doi: 10.1186/1747-5341-9-15.Google Scholar
  14. Ezeome, E.R., and C. Simon. 2010. Ethical problems in conducting research in acute epidemics: The Pfizer meningitis study in Nigeria as an illustration. Developing World Bioethics. doi: 10.1111/j.1471-8847.2008.00239.x.Google Scholar
  15. Gates, B. 2015. The next epidemic—Lessons from Ebola. New England Journal of Medicine 372: 1381–1384.CrossRefGoogle Scholar
  16. Goodman, J.L. 2014. Studying “secret serums”—Toward safe, effective Ebola treatments. New England Journal of Medicine 371: 1086–1089.CrossRefGoogle Scholar
  17. Iskander, J., R.A. Strikas, K.F. Gensheimer, N.J. Cox, and S.C. Redd. 2013. Pandemic influenza planning, United States, 1978–2008. Emerging Infectious Diseases. doi: 10.3201/eid1906.121478.Google Scholar
  18. Jennings, B., and J. Arras. 2008. Ethical guidance for public health emergency preparedness and response: Highlighting ethics and values in a vital public health service. http://www.cdc.gov/od/science/integrity/phethics/docs/White_Paper_Final_for_Website_2012_4_6_12_final_for_web_508_compliant.pdf. Accessed 6 Aug 2015, from United States Centers for Disease Control and Prevention Web site.
  19. Jeon, D.S., D.H. Kim, H.S. Kang, S.H. Hwang, J.H. Min, J.H. Kim, N.M. Sung, M.W. Carroll, and S.K. Park. 2009. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 13: 594–600.Google Scholar
  20. Joffe, S. 2014. Evaluating novel therapies during the Ebola epidemic. Journal of the American Medical Association 312: 1299–1300.CrossRefGoogle Scholar
  21. Jones, K.E., N.G. Patel, M.A. Levy, A. Storeygard, D. Balk, J.L. Gittleman, and P. Daszak. 2008. Global trends in emerging infectious diseases. Nature 451: 990–994.CrossRefGoogle Scholar
  22. Kass, N. 2014. Ebola, ethics, and public health: What next? Annals of Internal Medicine 161: 744–745.CrossRefGoogle Scholar
  23. Kinlaw, K., and R. Levine. 2007. Ethical guidelines in pandemic influenza. http://www.cdc.gov/od/science/integrity/phethics/panFlu_Ethic_Guidelines.pdf. Accessed 6 Aug 2015, from United States Centers for Disease Control and Prevention Web site.
  24. Klopper, M., R.M. Warren, C. Hayes, N.C.G. van Pittius, E.M. Steicher, B. Müller, F.A. Sirgel, M. Chabula-Nxiweni, E. Hoosain, G. Coetzee, P.D. van Helden, T.C. Victor, and A.P. Trollip. 2013. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerging Infectious Diseases 19: 449–455.CrossRefGoogle Scholar
  25. Lange, C., I. Abubakar, J.C. Alffenaar, G. Bothamley, J.A. Caminero, A.C.C. Carvalho, et al. 2014. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: A TBNET consensus statement. European Respiratory Journal 44: 23–63.CrossRefGoogle Scholar
  26. Littman, J. 2014. How high is a high risk? Prioritizing high-risk individuals in an influenza pandemic. Vaccine 32: 7167–7170.CrossRefGoogle Scholar
  27. McDougall, C.W. 2010. A survey of ethical principles and guidance within selected pandemic plans. http://www.ncchpp.ca/docs/EthicsPandemicPlans_EN.pdf. Accessed 6 Aug 2015, from National Collaborating Centre for Healthy Public Policy Web site.
  28. Médecins Sans Frontières. 2015. Pushed to the limit and beyond: A year into the largest ever Ebola outbreak. https://www.doctorswithoutborders.org/sites/usa/files/msf143061.pdf. Accessed 6 Aug 2015, from Doctors Without Borders Web site.
  29. Mounier-Jack, S., R. Jas, and R. Coker. 2007. Progress and shortcomings in European national strategic plans for pandemic influenza. Bulletin of the World Health Organization 85: 923–929.CrossRefGoogle Scholar
  30. National Ethics Advisory Committee. 2007. Getting through together: Ethical values for a pandemic. http://neac.health.govt.nz/system/files/documents/publications/getting-through-together-jul07.pdf. Accessed 6 Aug 2015.
  31. Prehn, A.W., and D.E. Vawter. 2008. Ethical guidance for rationing scarce health-related resources in a severe influenza pandemic: Literature and plan review. http://www.health.state.mn.us/divs/idepc/ethics/litrev.pdf. Accessed 6 Aug 2015, from Minnesota Department of Health Web site.
  32. Presidential Commission for the Study of Bioethics. 2015. Ethics and Ebola: Public health planning and response. http://bioethics.gov/sites/default/files/Ethics-and-Ebola_PCSBI_508.pdf. Accessed 6 Aug 2015.
  33. Public Health Agency of Canada. 2011. The Canadian pandemic influenza plan for the health sector. http://www.phac-aspc.gc.ca/cpip-pclcpi/index-eng.php. Accessed 6 Aug 2015.
  34. Rid, A., and E.J. Emanuel. 2014. Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet 384: 1896–1899.Google Scholar
  35. Save the Children. 2015. A wake-up call: Lessons from Ebola for the worlds health systems. http://www.savethechildren.org/atf/cf/%7B9def2ebe-10ae-432c-9bd0-df91d2eba74a%7D/WAKE%20UP%20CALL%20REPORT%20PDF.PDF. Accessed 6 Aug 2015.
  36. Schuklenk, U. 2014. Bioethics and the Ebola outbreak in West Africa. Developing World Bioethics. doi: 10.1111/dewb.12073.Google Scholar
  37. Selgelid, M. 2005. Ethics and infectious disease. Bioethics. doi: 10.1111/j.1467-8519.2005.00441.x.Google Scholar
  38. Selgelid, M.J. 2008. Ethics, tuberculosis and globalization. Public Health Ethics 1: 10–20.CrossRefGoogle Scholar
  39. Silva, D.S., and M.J. Smith. 2015. Limiting rights and freedoms in the context of Ebola and other public health emergencies: How the principle of reciprocity can enrich the application of the Siracusa Principles. Health and Human Rights Journal 17: E52–E57.CrossRefGoogle Scholar
  40. Singh, J.A., R. Upshur, and N. Padayatchi. 2007. XDR-TB in South Africa: No time for denial or complacency. PLOS Medicine. doi: 10.1371/journal.pmed.0040050.Google Scholar
  41. Smith, M.J., and R. Upshur. 2015. Ebola and learning lessons from moral failures: Who cares about ethics? Public Health Ethics. doi: 10.1093/phe/phv028.
  42. Thomas, J.C., N. Dasgupta, and A. Marinot. 2007. Ethics in a pandemic: A survey of the state pandemic influenza plans. American Journal of Public Health 97: S26–S31.CrossRefGoogle Scholar
  43. United Nations Development Programme. 2015. Recovering from the Ebola crisis. http://www.undp.org/content/dam/undp/library/crisis%20prevention/Recovering%20from%20the%20Ebola%20Crisis-Full-Report-Final_Eng-web-version.pdf. Accessed 6 Aug 2015.
  44. United States Centers for Disease Control and Prevention. 2012. Basic TB facts. http://www.cdc.gov/tb/topic/basics/default.htm. Accessed 6 Aug 2015.
  45. United States Centers for Disease Control and Prevention. 2013. All-hazards preparedness guide. http://www.cdc.gov/phpr/documents/ahpg_final_march_2013.pdf. Accessed 6 Aug 2015.
  46. United States Centers for Disease Control and Prevention. 2015. Clinical signs and symptoms of influenza. http://www.cdc.gov/flu/professionals/acip/clinical.htm. Accessed 6 Aug 2015.
  47. United States Department of Health and Human Services. 2005. HHS pandemic influenza plan. http://www.flu.gov/planning-preparedness/federal/hhspandemicinfluenzaplan.pdf. Accessed 6 Aug 2015, from United States Department of Health and Human Services Flu.gov Web site.
  48. University of Toronto Joint Centre for Bioethics. 2005. Stand on guard for thee: Ethical considerations in preparedness planning for pandemic influenza. http://www.jcb.utoronto.ca/people/documents/upshur_stand_guard.pdf. Accessed 6 Aug 2015.
  49. Upshur, R.E.G. 2014. Ebola virus in West Africa: Waiting for the owl of Minerva. Journal of Bioethical Inquiry 11: 421–423.CrossRefGoogle Scholar
  50. Uscher-Pines, L., S.B. Omer, D.J. Barnett, T.A. Burke, and R.D. Balicer. 2006. Priority setting for pandemic influenza: An analysis of national preparedness plans. PLOS Medicine. doi: 10.1371/journal.pmed.0030436.Google Scholar
  51. Velayati, A.A., M.R. Masjedi, P. Farnia, P. Tabarsi, J. Ghanavi, A.H. Ziazarifi, and S.E. Hoffner. 2009. Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest 136: 420–425.CrossRefGoogle Scholar
  52. Viens, A.M., and J. Litmman. 2015. Is antimicrobial resistance a slowly emerging disaster? Public Health Ethics. doi: 10.1093/phe/phv015.Google Scholar
  53. Viens, A.M., C.M. Bensimon, and R.E.G. Upshur. 2009. Your liberty or your life: Reciprocity in the use of restrictive measures in contexts of contagion. Journal of Bioethical Inquiry 6: 207–217.CrossRefGoogle Scholar
  54. World Health Organization. 2004. Guidance on ethics and equitable access to HIV treatment and care. http://www.who.int/ethics/en/ethics_equity_HIV_e.pdf?ua=1. Accessed 6 Aug 2015.
  55. World Health Organization. 2005a. WHO global influenza preparedness plan: The role of WHO and recommendations for national measure before and during pandemics. http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5.pdf. Accessed 6 Aug 2015.
  56. World Health Organization. 2005b. International health regulations. http://apps.who.int/iris/bitstream/10665/43883/1/9789241580410_eng.pdf. Accessed 6 Aug 2015.
  57. World Health Organization. 2007. Ethical considerations in developing a public health response to pandemic influenza. http://apps.who.int/iris/bitstream/10665/70006/1/WHO_CDS_EPR_GIP_2007.2_eng.pdf?ua=1&ua=1. Accessed 6 Aug 2015.
  58. World Health Organization. 2008a. Anti-tuberculosis drug resistance in the world. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf. Accessed 6 Aug 2015.
  59. World Health Organization. 2008b. Addressing ethical issues in pandemic influenza planning: Discussion papers. http://apps.who.int/iris/bitstream/10665/69902/1/WHO_IER_ETH_2008.1_eng.pdf?ua=1. Accessed 6 Aug 2015.
  60. World Health Organization. 2009. Pandemic influenza preparedness and response: A WHO guidance document. http://apps.who.int/iris/bitstream/10665/44123/1/9789241547680_eng.pdf. Accessed 6 Aug 2015.
  61. World Health Organization. 2011. Comparative analysis of national pandemic influenza preparedness plans. http://www.who.int/influenza/resources/documents/comparative_analysis_php_2011_en.pdf?ua=1. Accessed 6 Aug 2015.
  62. World Health Organization. 2012. Drug-resistant tuberculosis. http://www.who.int/tb/challenges/mdr/tdrfaqs/en/. Accessed 6 Aug 2015.
  63. World Health Organization. 2014a. Ethical considerations for the use of unregistered interventions for Ebola viral disease. http://apps.who.int/iris/bitstream/10665/130997/1/WHO_HIS_KER_GHE_14.1_eng.pdf?ua=1. Accessed 6 Aug 2015.
  64. World Health Organization. 2014b. Global tuberculosis report 2014. http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf. Accessed 6 Aug 2015.
  65. World Health Organization. 2015a. Report of the Ebola interim assessment panel (July 2015). http://www.who.int/csr/resources/publications/ebola/report-by-panel.pdf?ua=1. Accessed 6 Aug 2015.
  66. World Health Organization. 2015b. Emergencies preparedness, response. http://www.who.int/csr/en/. Accessed 6 Aug 2015.
  67. World Health Organization. 2015c. MERS-CoV outbreak largest outside Kingdom of Saudi Arabia. http://www.who.int/mediacentre/news/mers/briefing-notes/2-june-2015-republic-of-korea/en/. Accessed 6 Aug 2015.
  68. World Health Organization. 2015d. FAQs: H5N1 influenza. http://www.who.int/influenza/human_animal_interface/avian_influenza/h5n1_research/faqs/en/. Accessed 6 Aug 2015.
  69. World Health Organization. 2015e. Global outbreak alert and response network (GOARN). http://www.who.int/ihr/alert_and_response/outbreak-network/en/. Accessed 6 Aug 2015.
  70. Yakubu, A., M.O. Folayan, N. Sani-Gwarzo, P. Nguku, K. Peterson, and B. Brown. 2014. The Ebola outbreak in western Africa: Ethical obligations for care. Journal of Medical Ethics. doi: 10.1136/medethics-2014-102434.Google Scholar

Copyright information

© Monash University 2015

Authors and Affiliations

  1. 1.Dalla Lana School of Public Health and Joint Centre for BioethicsUniversity of TorontoTorontoCanada
  2. 2.Faculty of Health SciencesSimon Fraser UniversityBurnabyCanada

Personalised recommendations